Cymra’s flagship clinical product Cybis is now released an on the market through our distributor. Its Australian grown cannabis under Good Agricultural Practice and Australian manufactured under Good Manufacturing Practice.
Full spectrum profile with Linalool the dominant terpene, alongside bisabolol and betacaryophellene providing potential benefits of the entourage effects. Linalool has shown to reduce anxiety through human clinical trials.
Formulation:
10mg THC
25mg CBD
1mg Linalool
This formulation is specifically formulated for chronic pain patients. However, please consult your doctor to understand if cannabis is the right medication for you.
We have a registered clinical trial which is a dose escalation study assessing cannabis as a 2nd line therapy prior to opiate medications. We hope to prove that cannabis is a better alternative for long term chronic pain patients than opiates.
